Geron Corp
Research Geron Corp (GERN) on Bullrun: market cap USD 995.83M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerGERN
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 995.83M
- Financial periodQ2 2026
- RevenueUSD 57.48M
- Net income-USD 16.68M
- Free cash flow-USD 16.05M
- Gross margin83.9%
Valuation Snapshot
latest market cap is USD 995.83M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 183.88M | -USD 83.50M | -USD 111.09M | 97.4% | -0.13 | USD 77.56M | USD 119.55M | USD 225.87M |
| FY2024 | USD 76.99M | -USD 174.57M | -USD 219.30M | 98.4% | -0.27 | USD 79.02M | USD 118.48M | USD 280.32M |
| FY2023 | USD 237.00K | -USD 184.13M | -USD 168.57M | n/a | -0.32 | USD 70.02M | USD 81.94M | USD 247.95M |
| FY2022 | USD 596.00K | -USD 141.90M | -USD 127.81M | n/a | -0.37 | USD 56.85M | USD 51.16M | USD 80.00M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 995.83M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 844.61M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 2.15B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 1.15B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 922.59M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 394.95M | n/a | n/a | n/a |
About Geron Corp
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. The company's product pipeline includes RYTELO, a telomerase inhibitor for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia; IMerge which is in Phase 3 clinical trial for the treatment of lower-risk myelodysplastic syndromes; IMpactMF that is in Phase 3 for the treatment of relapsed/refractory myelofibrosis;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Geron Corp's market cap?
Geron Corp's market capitalization is USD 995.83M.
What does Geron Corp do?
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.